Srishti Gupta
Director/Board Member at IDORSIA LTD
Net worth: 37 108 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Paul Clozel | M | 69 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 7 years |
| Mathieu Simon | M | 68 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 5 years |
| Marc Elia | M | 48 | 2 years | |
| André Muller | M | 60 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 7 years |
| Christine Regan Lindenboom | F | 43 | 2 years | |
| Julien Gander | M | 45 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | - |
| Jill Andersen | F | 51 | 3 years | |
| Jörn Aldag | M | 65 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 4 years |
| Terry McGuire | M | 68 | 4 years | |
| Sandy Mahatme | M | 59 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 4 years |
| Peter Kellogg | M | 67 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 3 years |
| Felix R. Ehrat | M | 67 |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | 4 years |
| Sara Cotter | F | 43 | 1 years | |
| Andrew C. Weiss | M | 55 | 7 years | |
| William Duke | M | 51 | 1 years | |
| Julie Green | F | 49 | - | |
| Tamsin Berry | F | 43 | 2 years | |
| Robert Allen | M | 55 | 1 years | |
| Alberto Gimona | M | 64 | 5 years | |
| Sophie Kornowski-Bonnet | M | 61 | 1 years | |
| Stacy Price | F | 55 | 1 years | |
| Simon Jose | M | 58 | 6 years | |
| Alexander Khatuntsev | M | 45 | 7 years | |
| Jeremy Gowler | M | 47 | 2 years | |
| Martine Clozel | M | 68 | 7 years | |
| Heidi Spurling | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Wyzga | M | 69 | 3 years | |
| Tomas Jan Heyman | M | 68 | 3 years | |
| Clive Meanwell | M | 67 | 2 years | |
| Guy Braunstein | M | 67 | 7 years | |
| Cristina A. Wilbur | F | 57 |
International School of the Basel Region AG
 International School of the Basel Region AG Other Consumer ServicesConsumer Services International School of the Basel Region AG provides primary and secondary school services. The private company is based in Reinach, Switzerland. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 16 | 51.61% |
| United States | 15 | 48.39% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Srishti Gupta
- Personal Network
